New JAMA Internal Medicine Editorial by Eric Widera, MD

Eric Widera, MD published an editorial in JAMA Internal Medicine highlighting why the push to adopt blood biomarkers for Alzheimer’s disease should not replace the essential role of primary care. He emphasizes that evaluating cognitive concerns must start with a clinically grounded functional assessment of how symptoms affect daily life, an approach that remains central to patient-centered care.

Read article here: "Importance of Function for Alzheimer Diagnosis and Management—More Than Memory"